InvestorsHub Logo
Followers 126
Posts 7338
Boards Moderated 1
Alias Born 12/03/2017

Re: None

Monday, 08/21/2023 10:38:48 AM

Monday, August 21, 2023 10:38:48 AM

Post# of 198922
Here's another question. Gries & Assc were engaged in Jan 2023 to perform the 2022 audit, which is still underway? 8 months later for 1 year that doesn't involve all of the nonsense that was in years up through 2020/2021? 8 months?

PCAOB AUDITORS
On January 11, 2021, the Company engaged Malone Bailey to perform the Audit for the years ended December 31, 2019
and 2020. The Company completed the client approval process in early February. No unanswered accounting issues
arose. It was determined in June of 2021 that the Bioclonetics transaction, which closed in November of 2020, should be
accounted for as a reverse merger rather than a business combination and will be reported as such in the audited
financials for ENZC. The requested change in accounting method required the books and records of Bioclonetics to be
audited for the years ended December 31, 2019 and 2020 in accordance with GAAP standards by a PCAOB auditor.
After the hiring of independent Accounting Consultants, it was determined that the Companies did do a business
combination not a reverse merger, and as of the time of this filing, the Company has provided all the records and
agreements, accounting memos and backup documentation requested by the consultant and the auditor. The Changes in
Accounting Method will result in amendments to the quarters ending March 31. 2021, June 30, 2021, and September 30,
2021 immediately upon completion of the audits. In July of 2022, the Company and Malone Bailey terminated their
relationship. There were no unresolved accounting or financial issues between the parties. Gries and Associates, LLC
was retained on July 18, 2022, and completed the 2020-2021 audit on December 16, 2022. Gries and Associates were
engaged in January 2023 to perform the 2022 Audit, which is currently underway
.